Carolina Liquid Chemistries Acquired by Diazyme Laboratories | Healthcare M&A Deal

Diazyme Laboratories has completed the acquisition of Carolina Liquid Chemistries, a diagnostics imaging business in California. Carolina Liquid Chemistries is an FDA-registered manufacturer and value-added reseller of chemistry systems and reagents, supporting chemistry analyzer workflows for reference and clinical laboratories. Diazyme Laboratories acquisitions expand its enzyme and immunoassay diagnostic test reagent portfolio by integrating CLC’s cost-effective, reliable products into its operations in Poway and across healthcare M&A networks. The add on acquisition is a strategic acquisition by a strategic buyer, with the deal status announced and the size undisclosed, positioning Diazyme to strengthen diagnostic capabilities for laboratories of all sizes.